World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
76
Citations
20473
World Ranking
1914
National Ranking
936

Research.com Recognitions

  • 2019 - Distinguished Fellows of the American Association of Immunologists (AAI)
  • 2016 - AAI Lifetime Achievement Award, American Association of Immunologists
  • 2016 - American Association of Immunologists Lifetime Achievement Award

Overview

Olivera J. Finn is affiliated with the University of Pittsburgh in the United States. Their research spans multiple fields including immunology, microbiology, medicine, and biochemistry, genetics, and molecular biology. Within these broader areas, their work focuses on subfields such as immunology, oncology, molecular biology, epidemiology, and biomedical engineering.

The scientist's research emphasizes several key topics including immunotherapy and immune responses, cancer immunotherapy and biomarkers, immune cells in cancer, glycosylation and glycoproteins research, vaccines and immunoinformatics approaches, CAR-T cell therapy research, and immune cell function and interaction.

Among their recent papers are:

  • Beneficial autoimmunity improves cancer prognosis, 2021, Nature Reviews Clinical Oncology
  • Post-translational covalent assembly of CAR and synNotch receptors for programmable antigen targeting, 2023, Nature Communications
  • Randomized, Double-Blind, Placebo-Controlled Trial of MUC1 Peptide Vaccine for Prevention of Recurrent Colorectal Adenoma, 2023, Clinical Cancer Research
  • Cancer vaccines, 2022, Cancer Cell
  • Altered Expression of the Epithelial Mucin MUC1 Accompanies Endoscopic Recurrence of Postoperative Crohn's Disease, 2020, Journal of Clinical Gastroenterology

Olivera J. Finn has collaborated frequently with several coauthors, including Camille M. Jacqueline, Pamela Beatty, Robert E. Schoen, Jason Lohmueller, and Jonathan S. Minden.

The scientist's work has been published repeatedly in several venues such as Cancer Research, bioRxiv (Cold Spring Harbor Laboratory), Frontiers in Immunology, Regular and Young Investigator Award Abstracts, and Cancer Immunology Research.

Recognition for their contributions includes several awards from the American Association of Immunologists (AAI), notably the Distinguished Fellows award in 2019 and the Lifetime Achievement Award in 2016.

Best Publications

  • The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research

    Martin A. Cheever;Martin A. Cheever;James P. Allison;Andrea S. Ferris;Olivera J. Finn

  • Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of t-cell function in advanced cancer patients.

    Jan Schmielau;Olivera J. Finn

  • Cancer vaccines: between the idea and the reality.

    Olivera J. Finn

  • Cancer Immunology

    Unknown

  • Specific, major histocompatibility complex-unrestricted recognition of tumor-associated mucins by human cytotoxic T cells

    Donna L. Barnd;Michael S. Lan;Richard S. Metzgar;Olivera J. Finn

  • Immuno-oncology: understanding the function and dysfunction of the immune system in cancer

    Unknown

  • Cytotoxic T-lymphocytes derived from patients with breast adenocarcinoma recognize an epitope present on the protein core of a mucin molecule preferentially expressed by malignant cells.

    Keith R. Jerome;Donna L. Barnd;Katharine M. Bendt;Cinda M. Boyer

  • Humoral immunity against a tandem repeat epitope of human mucin MUC-1 in sera from breast, pancreatic, and colon cancer patients

    Y Kotera;J D Fontenot;G Pecher;R S Metzgar

  • MUC-1 Epithelial Tumor Mucin-Based Immunity and Cancer Vaccines

    Olivera J. Finn;Keith R. Jerome;Robert A. Henderson;Gabriele Pecher

  • A phase I trial of a synthetic mucin peptide vaccine. Induction of specific immune reactivity in patients with adenocarcinoma

    James S. Goydos;Elaine Elder;Theresa L. Whiteside;Olivera J. Finn

  • MUC1 Vaccine for Individuals with Advanced Adenoma of the Colon: A Cancer Immunoprevention Feasibility Study

    Takashi Kimura;John R. McKolanis;Lynda A. Dzubinski;Kazi Islam

  • MCF7 Side Population Cells with Characteristics of Cancer Stem/Progenitor Cells Express the Tumor Antigen MUC1

    Katja Engelmann;Hongmei Shen;Olivera J. Finn

  • Cytotoxic T cells from ovarian malignant tumors can recognize polymorphic epithelial mucin core peptides.

    C G Ioannides;B Fisk;K R Jerome;T Irimura

  • The dawn of vaccines for cancer prevention

    Olivera J. Finn

  • Tumor-specific cytotoxic T cell clones from patients with breast and pancreatic adenocarcinoma recognize EBV-immortalized B cells transfected with polymorphic epithelial mucin complementary DNA.

    Keith R. Jerome;Nieves Domenech;Olivera J. Finn

  • Phase I study of a MUC1 vaccine composed of different doses of MUC1 peptide with SB-AS2 adjuvant in resected and locally advanced pancreatic cancer.

    Ramesh K. Ramanathan;Kenneth M. Lee;John McKolanis;Elizabeth Hitbold

  • Complex carbohydrates are not removed during processing of glycoproteins by dendritic cells: processing of tumor antigen MUC1 glycopeptides for presentation to major histocompatibility complex class II-restricted T cells.

    Anda M. Vlad;Stefan Muller;Mare Cudic;Hans Paulsen

  • A phase I/II study of a MUC1 peptide pulsed autologous dendritic cell vaccine as adjuvant therapy in patients with resected pancreatic and biliary tumors

    Andrew J Lepisto;Arthur J Moser;Herbert Zeh;Kenneth Lee

  • MUC1 Immunobiology: From Discovery to Clinical Applications

    Unknown

  • IL-33 synergizes with TCR and IL-12 signaling to promote the effector function of CD8+ T cells

    Qianting Yang;Gang Li;Gang Li;Yibei Zhu;Yibei Zhu;Lin Liu

  • Three Different Vaccines Based on the 140-Amino Acid MUC1 Peptide with Seven Tandemly Repeated Tumor-Specific Epitopes Elicit Distinct Immune Effector Mechanisms in Wild-Type Versus MUC1-Transgenic Mice with Different Potential for Tumor Rejection

    M. Melina Soares;Vinay Mehta;Olivera J. Finn

  • The Mechanism of Unresponsiveness to Circulating Tumor Antigen MUC1 Is a Block in Intracellular Sorting and Processing by Dendritic Cells

    Elizabeth M. Hiltbold;Anda M. Vlad;Pawel Ciborowski;Simon C. Watkins

  • Identification of an HLA-A11-restricted epitope from the tandem repeat domain of the epithelial tumor antigen mucin.

    N Doménech;R A Henderson;O J Finn

Frequent Co-Authors

Robert E. Schoen
Robert E. Schoen University of Pittsburgh
Theresa L. Whiteside
Theresa L. Whiteside University of Pittsburgh
Walter J. Storkus
Walter J. Storkus University of Pittsburgh
Michael T. Lotze
Michael T. Lotze University of Pittsburgh
Franz-Georg Hanisch
Franz-Georg Hanisch University of Cologne
Simon C. Watkins
Simon C. Watkins University of Pittsburgh
Daniel W. Cramer
Daniel W. Cramer Brigham and Women's Hospital
Ronald C. Montelaro
Ronald C. Montelaro University of Pittsburgh
Joyce Taylor-Papadimitriou
Joyce Taylor-Papadimitriou King's College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, exploring related healthcare fields can broaden career opportunities. Many professionals transition into nursing roles after building a strong science foundation. Those seeking swift entry into nursing might consider accelerated nursing programs, which offer a faster route to becoming a registered nurse.

Alternatively, starting with direct patient care roles like a Licensed Practical Nurse can be an excellent pathway. Programs labeled as easy lpn programs to get into simplify the admission process, helping candidates quickly begin hands-on nursing careers without exhaustive prerequisites.

Advancing beyond LPN roles, aspiring Advanced Practice Registered Nurses can benefit from easiest np programs to get into. These programs provide the necessary education to become nurse practitioners, enhancing scope of practice and professional autonomy.

Specializing in psychiatric care is another promising direction. The top online pmhnp programs offer excellent clinical placement rates, which are critical for gaining hands-on experience in mental health nursing while completing a degree online.

Best Scientists Citing Olivera J. Finn

Trending Scientists